MANA Advisors LLC bought a new position in Waters Co. (NYSE:WAT) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,553 shares of the medical instruments supplier’s stock, valued at approximately $493,000.
A number of other hedge funds have also recently modified their holdings of WAT. BlackRock Inc. raised its stake in Waters by 1.1% during the fourth quarter. BlackRock Inc. now owns 5,611,395 shares of the medical instruments supplier’s stock worth $1,084,065,000 after acquiring an additional 60,000 shares in the last quarter. Harding Loevner LP raised its stake in Waters by 207.1% during the third quarter. Harding Loevner LP now owns 2,768,174 shares of the medical instruments supplier’s stock worth $158,275,000 after acquiring an additional 1,866,848 shares in the last quarter. Janus Henderson Group PLC raised its stake in Waters by 1.6% during the third quarter. Janus Henderson Group PLC now owns 1,959,850 shares of the medical instruments supplier’s stock worth $351,832,000 after acquiring an additional 30,057 shares in the last quarter. Renaissance Technologies LLC raised its stake in Waters by 59.1% during the fourth quarter. Renaissance Technologies LLC now owns 1,429,049 shares of the medical instruments supplier’s stock worth $276,078,000 after acquiring an additional 530,949 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Waters by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 904,436 shares of the medical instruments supplier’s stock worth $174,391,000 after acquiring an additional 27,215 shares in the last quarter. 94.06% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have issued reports on WAT shares. Janney Montgomery Scott increased their price objective on Waters from $200.00 to $230.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. BTIG Research started coverage on Waters in a research note on Friday, January 5th. They set a “buy” rating and a $230.00 price objective for the company. Zacks Investment Research upgraded Waters from a “hold” rating to a “buy” rating and set a $217.00 price objective for the company in a research note on Tuesday, December 26th. Barclays raised their target price on Waters from $202.00 to $208.00 and gave the company an “equal weight” rating in a research note on Wednesday, January 24th. Finally, Morgan Stanley upgraded Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 target price for the company in a research note on Monday, December 4th. Thirteen equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $203.75.
Waters Co. (NYSE WAT) opened at $212.70 on Friday. The stock has a market capitalization of $16,757.36, a PE ratio of 28.36, a P/E/G ratio of 2.55 and a beta of 0.91. Waters Co. has a 1-year low of $153.04 and a 1-year high of $220.20. The company has a quick ratio of 6.60, a current ratio of 7.04 and a debt-to-equity ratio of 0.85.
Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.07. The business had revenue of $687.28 million for the quarter, compared to analysts’ expectations of $671.98 million. Waters had a return on equity of 24.70% and a net margin of 0.88%. The firm’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter last year, the business earned $2.21 earnings per share. equities analysts forecast that Waters Co. will post 8.16 EPS for the current year.
WARNING: This report was first posted by Week Herald and is owned by of Week Herald. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://weekherald.com/2018/03/11/mana-advisors-llc-takes-493000-position-in-waters-co-wat.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.